Label: VIVARIN- caffeine tablet

  • NDC Code(s): 71179-018-16, 71179-018-40, 71179-018-60
  • Packager: VESPYR BRANDS, INC.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 31, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

    Active ingredient (in each tablet)

    Caffeine 200mg


  • Purpose

    Alertness aid

  • Use

    Helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

  • Warnings

    Do not use

    • as a substitute for sleep. This product is intended for occasional use only.
    • in children under 12 years of age
  • When using this product

    limit the use of caffeine-containing medications, foods, or beverages because too much caffeine may cause nervousness, irritability, sleeplessness, and occasionally, rapid heartbeat. The recommended dose of this product contains about as much caffeine as a cup of coffee.

  • Stop use and ask a doctor if

    fatigue or drowsiness persists or continues to recur.

  • If pregnant or breast-feeding,

    ask a health professional before use.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    Adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours.

  • Other information

    • each tablet contains calcium 60 mg
    • store in a dry place at 15° - 30°C (59° - 86°F)
    • avoid excessive heat (greater than 100°F) or humidity
  • Inactive ingredients

    colloidal silicon dioxide, croscarmellose sodium, D&C yellow #10 aluminum lake, dicalcium phosphate dihydrate, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, corn starch, titanium dioxide

  • Questions or comments?

    Call toll-free 1-855-874-0970weekdays

    DISTRIBUTED BY:
    Vespyr Brands®, Inc.
    East Windsor, NJ 08520

    Made in India

    Code: TS/DRUGS/16/2014

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL 200 mg (16 Tablets Container Carton)

    NDC 71179-018-16

    V

    VIVARIN®
    CAFFEINE ALERTNESS AID

    16 Tablets |  200 mg Each
    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL 200 mg (16 Tablets Container Carton)

  • INGREDIENTS AND APPEARANCE
    VIVARIN 
    caffeine tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71179-018
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E) CAFFEINE200 mg
    Inactive Ingredients
    Ingredient NameStrength
    CARNAUBA WAX (UNII: R12CBM0EIZ)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    D&C YELLOW NO. 10 ALUMINUM LAKE (UNII: CQ3XH3DET6)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColoryellowScoreno score
    ShapeROUNDSize11mm
    FlavorImprint Code V;V
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71179-018-162 in 1 CARTON06/19/2023
    18 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:71179-018-405 in 1 CARTON06/19/2023
    28 in 1 BLISTER PACK; Type 0: Not a Combination Product
    3NDC:71179-018-601 in 1 CARTON01/02/2024
    360 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01106/19/2023
    Labeler - VESPYR BRANDS, INC. (118094893)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!